StockNews.com upgraded shares of DexCom (NASDAQ:DXCM – Free Report) from a hold rating to a buy rating in a research note published on Friday. DXCM has been the subject of several other reports. Canaccord Genuity Group upped their target price on shares of DexCom from $144.00 to $145.00 and gave the stock a buy rating […]